Abbott Laboratories (ABT) EBT Margin (2009 - 2026)
Abbott Laboratories recorded quarterly EBT Margin of 12.98% in Q1 2026, down 36.93% quarter-over-quarter from 20.58% in Q4 2025, and down 419.0% year-over-year from 4.07% in Q1 2025.
Abbott Laboratories' EBT Margin history runs 18 years deep, the most recent figure standing at 12.98% for Q1 2026.
- In Q1 2026, EBT Margin fell 419.0% year-over-year to 12.98%; the TTM figure through Mar 2026 stood at 18.03% (up 66.0% YoY), while the FY2025 annual figure was 19.1%, up 238.0% from the prior year.
- EBT Margin came in at 12.98% for Q1 2026 at Abbott Laboratories, down from 20.58% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 24.18% in Q1 2022 to a low of 12.98% in Q1 2026.
- A 5-year average of 17.49% and a median of 17.17% in 2025 frame the typical range for EBT Margin.
- Across the five-year window, EBT Margin soared 771 bps in 2022 and sank 815 bps in 2023, its largest moves.
- Abbott Laboratories' EBT Margin stood at 13.08% in 2022, then jumped by 34 bps to 17.53% in 2023, then grew by 6 bps to 18.5% in 2024, then climbed by 11 bps to 20.58% in 2025, then plunged by 37 bps to 12.98% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 12.98%, 20.58%, and 19.17% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 15.57% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 27.84% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4.87% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 22.61% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.84% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.17% |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 14.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.98% |
| Dec 31, 2025 | 20.58% |
| Sep 30, 2025 | 19.17% |
| Jun 30, 2025 | 19.30% |
| Mar 31, 2025 | 17.17% |
| Dec 31, 2024 | 18.50% |
| Sep 30, 2024 | 18.24% |
| Jun 30, 2024 | 15.49% |
| Mar 31, 2024 | 14.41% |
| Dec 31, 2023 | 17.53% |
| Sep 30, 2023 | 16.47% |
| Jun 30, 2023 | 16.40% |
| Mar 31, 2023 | 16.03% |
| Dec 31, 2022 | 13.08% |
| Sep 30, 2022 | 16.89% |
| Jun 30, 2022 | 20.89% |
| Mar 31, 2022 | 24.18% |
| Dec 31, 2021 | 20.29% |
| Sep 30, 2021 | 22.81% |
| Jun 30, 2021 | 13.19% |
| Mar 31, 2021 | 19.54% |
| Dec 31, 2020 | 22.32% |
| Sep 30, 2020 | 16.05% |
| Jun 30, 2020 | 7.18% |
| Mar 31, 2020 | 8.19% |
| Dec 31, 2019 | 4.22% |
| Sep 30, 2019 | 13.66% |
| Jun 30, 2019 | 13.81% |
| Mar 31, 2019 | 8.39% |
| Dec 31, 2018 | 12.20% |
| Sep 30, 2018 | 9.38% |
| Jun 30, 2018 | 10.00% |
| Mar 31, 2018 | 5.83% |
| Dec 31, 2017 | 7.56% |
| Sep 30, 2017 | 9.17% |
| Jun 30, 2017 | 4.44% |
| Mar 31, 2017 | 11.62% |
| Dec 31, 2016 | 16.41% |
| Sep 30, 2016 | -3.38% |
| Jun 30, 2016 | 13.41% |
| Mar 31, 2016 | 0.04% |
| Dec 31, 2015 | 0.79% |
| Sep 30, 2015 | 13.86% |
| Jun 30, 2015 | 19.07% |
| Mar 31, 2015 | 13.33% |
| Dec 31, 2014 | -24.68% |
| Sep 30, 2014 | 14.08% |
| Jun 30, 2014 | 13.01% |
| Mar 31, 2014 | 7.17% |
| Dec 31, 2013 | 11.99% |
| Sep 30, 2013 | 10.01% |
| Jun 30, 2013 | 12.18% |
| Mar 31, 2013 | 11.43% |
| Dec 31, 2012 | -49.81% |
| Sep 30, 2012 | 4.39% |
| Jun 30, 2012 | 9.97% |
| Mar 31, 2012 | 8.77% |
| Dec 31, 2011 | -13.64% |
| Sep 30, 2011 | 5.11% |
| Jun 30, 2011 | 17.41% |
| Mar 31, 2011 | 11.82% |
| Dec 31, 2010 | -42.34% |
| Sep 30, 2010 | 12.27% |
| Jun 30, 2010 | 17.66% |
| Mar 31, 2010 | 17.18% |
| Dec 31, 2009 | 20.74% |
| Sep 30, 2009 | 24.11% |
| Jun 30, 2009 | 20.91% |